Mitochondrial fusion as a therapeutic target for regenerative medicine

Mitochondria constantly change shape through fusion and fission. This dynamic behavior is now recognized as a pivotal regulator of cellular plasticity, survival, and repair. When fusion is impaired, mitochondria become excessively fragmented, cells become less efficient at producing energy, and more susceptible to cellular damage and stressors. When fusion is intact, mitochondria form a connected network that supports efficient energy production, stress resistance, and cellular function. This review examines how mitochondrial fusion influences cellular plasticity and tissue regeneration, and how loss of fusion contributes to disease. We first describe how two sets of proteins on the outer and inner mitochondrial membranes work together to drive fusion, and how they are controlled by local signals and by their interplay with fission proteins. We then summarize evidence that displays how loss of fusion contributes to aging, inherited mitochondrial disorders, neurodegenerative diseases, chronic inflammatory states, in part by weakening cellular energy production and quality control. In parallel, we highlight studies showing that promoting mitochondrial fusion can rescue cells from short‑lived, stress‑prone states to more mature, resilient, and functionally specialized states which improve differentiation and function of stem cells and progenitor cells favoring tissue repair and maintenance. Building on these concepts, this review outlines three major therapeutic directions: drugs that act directly on fusion proteins, approaches that modulate upstream signaling pathways that control fusion, and cell‑based strategies such as gene delivery and mitochondrial transplantation. Preclinical studies suggest that boosting fusion can improve outcomes in models of inherited nerve disease, brain injury, heart and kidney ischemia, and musculoskeletal degeneration. Notably, mitochondrial transplantation may work in part by rebuilding a healthy, interconnected mitochondrial network in injured cells, rather than merely increasing mitochondrial number. Finally, we discuss how fusion‑targeted therapies could be combined with existing regenerative approaches, such as stem cell treatments and biomaterials, to more effectively restore tissue structure and function.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-12
DOI
https://doi.org/10.1186/s12967-026-09044-7
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mitochondrial fusion as a therapeutic target for regenerative medicine

Pooja N. Swami, Parmeshar Singh, Jun Hwan Kim, Henintsoa Fanjaniaina Andriamifidy et al.
Journal of Translational Medicine
Mitochondrial Function and Pathology
article

Mitochondrial fusion as a therapeutic target for regenerative medicine

Pooja N. Swami, Parmeshar Singh, Jun Hwan Kim, Henintsoa Fanjaniaina Andriamifidy, Daniel A. Grande, Mohammed Azhar Khan
article en

Abstract

Mitochondria constantly change shape through fusion and fission. This dynamic behavior is now recognized as a pivotal regulator of cellular plasticity, survival, and repair. When fusion is impaired, mitochondria become excessively fragmented, cells become less efficient at producing energy, and more susceptible to cellular damage and stressors. When fusion is intact, mitochondria form a connected network that supports efficient energy production, stress resistance, and cellular function. This review examines how mitochondrial fusion influences cellular plasticity and tissue regeneration, and how loss of fusion contributes to disease. We first describe how two sets of proteins on the outer and inner mitochondrial membranes work together to drive fusion, and how they are controlled by local signals and by their interplay with fission proteins. We then summarize evidence that displays how loss of fusion contributes to aging, inherited mitochondrial disorders, neurodegenerative diseases, chronic inflammatory states, in part by weakening cellular energy production and quality control. In parallel, we highlight studies showing that promoting mitochondrial fusion can rescue cells from short‑lived, stress‑prone states to more mature, resilient, and functionally specialized states which improve differentiation and function of stem cells and progenitor cells favoring tissue repair and maintenance. Building on these concepts, this review outlines three major therapeutic directions: drugs that act directly on fusion proteins, approaches that modulate upstream signaling pathways that control fusion, and cell‑based strategies such as gene delivery and mitochondrial transplantation. Preclinical studies suggest that boosting fusion can improve outcomes in models of inherited nerve disease, brain injury, heart and kidney ischemia, and musculoskeletal degeneration. Notably, mitochondrial transplantation may work in part by rebuilding a healthy, interconnected mitochondrial network in injured cells, rather than merely increasing mitochondrial number. Finally, we discuss how fusion‑targeted therapies could be combined with existing regenerative approaches, such as stem cell treatments and biomaterials, to more effectively restore tissue structure and function.

Journal of Translational Medicine
Feinstein Institute for Medical Research (US), Hofstra University (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Shoolini University (IN)
Good health and well-being
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon